Matijević, Milica

Link to this page

Authority KeyName Variants
orcid::0000-0002-9846-6671
  • Matijević, Milica (11)
Projects

Author's Bibliography

A novel PGA/TiO2 nanocomposite prepared with poly(γ-glutamic acid) from the newly isolated Bacillus subtilis 17B strain

Šokarda Slavić, Marinela; Ralić, Vanja; Nastasijević, Branislav; Matijević, Milica; Vujčić, Zoran; Margetić, Aleksandra

(2023)

TY  - JOUR
AU  - Šokarda Slavić, Marinela
AU  - Ralić, Vanja
AU  - Nastasijević, Branislav
AU  - Matijević, Milica
AU  - Vujčić, Zoran
AU  - Margetić, Aleksandra
PY  - 2023
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/11988
AB  - Poly(γ-glutamic acid) (PGA), naturally produced by Bacillus species, is a biodegradable, non-toxic, biocompatible, and non-immunogenic negatively charged polymer. Due to its properties, it has found various applications in the food, cosmetic and pharmaceutical industries. In this work, Bacillus subtilis 17B was selected as the best PGA producer among fifty wild-types Bacillus strains tested and characterized as a glutamate-independent producer. The production of PGA by the newly identified strain was optimized and increased tenfold using the Box-Behnken experimental design. The purity of PGA after recovery and purification from the fermentation broth was confirmed by SDS-PAGE followed by Methylene Blue staining. PGA was characterized by ESI MS and used for the preparation of a new nanocomposite with TiO2. The synthesis of PGA/TiO2 nanocomposite, its structural analysis, and cytotoxic effect on the cervical cancer cell line (HeLa cell) was investigated to determine the potential anti-cancer usage of this newly prepared material. Encouraging, PGA/TiO2 nanocomposite showed an increased cytotoxic effect compared to TiO2 alone.
AB  - Поли(γ-глутаминска киселина) (ПГK), коју производе бактерије рода Bacillus, је биоразградив, нетоксичан, биокомпатибилан и неимуноген негативно наелектрисани полимер. Због својих својстава нашао је разноврсну примену у прехрамбеној, козметичкој и фармацеутској индустрији. У овом раду, Bacillus ѕubtilis 17Б је изабран као најбољи ПГК продуцер међу педесетак тестираних природних изолата бактерија из овог рода и окарактерисан као глутамат независтан продуцер. Производња ПГК овим новоидентификованим сојем је оптимизована и десетоструко увећана коришћењем Box-Behnken експерименталног дизајна. Чистоћа ПГК након изоловања и пречишћавања из ферметационе течности је потврђена електрофорезом (SDS-PAGE) након бојења метиленским плавим. ПГК је окарактерисана масеном спекроскопијом (ESI MS) и коришћена за добијање новог нанокомпозита са ТiО2. Синтеза ПГК/ТiО2 нанокомпозита, његова структурна анализа и цитотоксични ефекат на ћелијску линију рака грлића материце (HeLa ћелије) је испитан да би се утврдила потенцијална употреба овог новодобијеног материјала у борби против ћелија рака. Нанокомпозит ПГК/ТiО2показао је повећан цитотоксични ефекат на поменуте ћелије рака у поређењу са самим ТiО2.
T2  - Journal of the Serbian Chemical Society
T1  - A novel PGA/TiO2 nanocomposite prepared with poly(γ-glutamic acid) from the newly isolated Bacillus subtilis 17B strain
T1  - Нови ПГК/TiO2 нанокомпозит добијен од поли(γ -глутаминске киселине) из новоизолованог соја bacillus subtilis 17B
VL  - 88
IS  - 10
SP  - 985
EP  - 997
DO  - 10.2298/JSC221116011S
ER  - 
@article{
author = "Šokarda Slavić, Marinela and Ralić, Vanja and Nastasijević, Branislav and Matijević, Milica and Vujčić, Zoran and Margetić, Aleksandra",
year = "2023",
abstract = "Poly(γ-glutamic acid) (PGA), naturally produced by Bacillus species, is a biodegradable, non-toxic, biocompatible, and non-immunogenic negatively charged polymer. Due to its properties, it has found various applications in the food, cosmetic and pharmaceutical industries. In this work, Bacillus subtilis 17B was selected as the best PGA producer among fifty wild-types Bacillus strains tested and characterized as a glutamate-independent producer. The production of PGA by the newly identified strain was optimized and increased tenfold using the Box-Behnken experimental design. The purity of PGA after recovery and purification from the fermentation broth was confirmed by SDS-PAGE followed by Methylene Blue staining. PGA was characterized by ESI MS and used for the preparation of a new nanocomposite with TiO2. The synthesis of PGA/TiO2 nanocomposite, its structural analysis, and cytotoxic effect on the cervical cancer cell line (HeLa cell) was investigated to determine the potential anti-cancer usage of this newly prepared material. Encouraging, PGA/TiO2 nanocomposite showed an increased cytotoxic effect compared to TiO2 alone., Поли(γ-глутаминска киселина) (ПГK), коју производе бактерије рода Bacillus, је биоразградив, нетоксичан, биокомпатибилан и неимуноген негативно наелектрисани полимер. Због својих својстава нашао је разноврсну примену у прехрамбеној, козметичкој и фармацеутској индустрији. У овом раду, Bacillus ѕubtilis 17Б је изабран као најбољи ПГК продуцер међу педесетак тестираних природних изолата бактерија из овог рода и окарактерисан као глутамат независтан продуцер. Производња ПГК овим новоидентификованим сојем је оптимизована и десетоструко увећана коришћењем Box-Behnken експерименталног дизајна. Чистоћа ПГК након изоловања и пречишћавања из ферметационе течности је потврђена електрофорезом (SDS-PAGE) након бојења метиленским плавим. ПГК је окарактерисана масеном спекроскопијом (ESI MS) и коришћена за добијање новог нанокомпозита са ТiО2. Синтеза ПГК/ТiО2 нанокомпозита, његова структурна анализа и цитотоксични ефекат на ћелијску линију рака грлића материце (HeLa ћелије) је испитан да би се утврдила потенцијална употреба овог новодобијеног материјала у борби против ћелија рака. Нанокомпозит ПГК/ТiО2показао је повећан цитотоксични ефекат на поменуте ћелије рака у поређењу са самим ТiО2.",
journal = "Journal of the Serbian Chemical Society",
title = "A novel PGA/TiO2 nanocomposite prepared with poly(γ-glutamic acid) from the newly isolated Bacillus subtilis 17B strain, Нови ПГК/TiO2 нанокомпозит добијен од поли(γ -глутаминске киселине) из новоизолованог соја bacillus subtilis 17B",
volume = "88",
number = "10",
pages = "985-997",
doi = "10.2298/JSC221116011S"
}
Šokarda Slavić, M., Ralić, V., Nastasijević, B., Matijević, M., Vujčić, Z.,& Margetić, A.. (2023). A novel PGA/TiO2 nanocomposite prepared with poly(γ-glutamic acid) from the newly isolated Bacillus subtilis 17B strain. in Journal of the Serbian Chemical Society, 88(10), 985-997.
https://doi.org/10.2298/JSC221116011S
Šokarda Slavić M, Ralić V, Nastasijević B, Matijević M, Vujčić Z, Margetić A. A novel PGA/TiO2 nanocomposite prepared with poly(γ-glutamic acid) from the newly isolated Bacillus subtilis 17B strain. in Journal of the Serbian Chemical Society. 2023;88(10):985-997.
doi:10.2298/JSC221116011S .
Šokarda Slavić, Marinela, Ralić, Vanja, Nastasijević, Branislav, Matijević, Milica, Vujčić, Zoran, Margetić, Aleksandra, "A novel PGA/TiO2 nanocomposite prepared with poly(γ-glutamic acid) from the newly isolated Bacillus subtilis 17B strain" in Journal of the Serbian Chemical Society, 88, no. 10 (2023):985-997,
https://doi.org/10.2298/JSC221116011S . .

ROS-mediated proapoptotic antitumor effects of Ru(II) complex on pancreatic cancer cells

Čolakov, Katarina; Nešić, Maja D.; Matijević, Milica; Stepić, Milutin; Petković, Marijana; Korićanac, Lela; Žakula, Jelena

(Belgrade : Faculty of Chemistry : Serbian Biochemical Society, 2022)

TY  - CONF
AU  - Čolakov, Katarina
AU  - Nešić, Maja D.
AU  - Matijević, Milica
AU  - Stepić, Milutin
AU  - Petković, Marijana
AU  - Korićanac, Lela
AU  - Žakula, Jelena
PY  - 2022
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/11011
AB  - Existing therapies for the treatment of pancreatic cancer are insufficiently effective and accompanied by a large number of side effects. Ruthenium complexes have shown promising antitumor properties in the previous studies 1,2 . Thus, in this investigation, anticancer effects of cis-dichlorobis (2,2'-bipyridyl-4,4'dicarboxylic acid)ruthenium(II) (Ru(II) complex) were evaluated using human pancreatic carcinoma cell lines MIA PaCa-2 and PANC-1 in vitro. Cell viability estimated with SRB assay showed significant antitumor activity of Ru(II) complex on MIA PaCa-2 (~55% of control) 48 and 72 h after treatment. On the other hand, PANC-1 cell viability was decreased only 72 h after treatment with the highest concentration of Ru(II) complex (~70% of control). Seven days after the treatment, analysis of cell survival using clonogenic assay showed a significant decrease in cell growth in both cell lines. Ru(II) complex also caused G 1 cell cycle arrest of ~13% in both cell lines. The highest percentage of apoptotic MIA PaCa-2 cells was obtained 48 h after treatment. In addition, the intracellular level of reactive oxygen species (ROS) was significantly increased, whereas cell migration was reduced in both cell lines. Summarized, Ru(II)complex demonstrates antitumor properties mediated by increased oxidative stress and also implies the antimetastatic potential, which deserves further study.
PB  - Belgrade : Faculty of Chemistry : Serbian Biochemical Society
C3  - Serbian Biochemical Society : 11th conference - "Amazing Biochemistry" : proceedings ; September 22-23, 2022; Novi Sad, Serbia
T1  - ROS-mediated proapoptotic antitumor effects of Ru(II) complex on pancreatic cancer cells
SP  - 155
UR  - https://hdl.handle.net/21.15107/rcub_vinar_11011
ER  - 
@conference{
author = "Čolakov, Katarina and Nešić, Maja D. and Matijević, Milica and Stepić, Milutin and Petković, Marijana and Korićanac, Lela and Žakula, Jelena",
year = "2022",
abstract = "Existing therapies for the treatment of pancreatic cancer are insufficiently effective and accompanied by a large number of side effects. Ruthenium complexes have shown promising antitumor properties in the previous studies 1,2 . Thus, in this investigation, anticancer effects of cis-dichlorobis (2,2'-bipyridyl-4,4'dicarboxylic acid)ruthenium(II) (Ru(II) complex) were evaluated using human pancreatic carcinoma cell lines MIA PaCa-2 and PANC-1 in vitro. Cell viability estimated with SRB assay showed significant antitumor activity of Ru(II) complex on MIA PaCa-2 (~55% of control) 48 and 72 h after treatment. On the other hand, PANC-1 cell viability was decreased only 72 h after treatment with the highest concentration of Ru(II) complex (~70% of control). Seven days after the treatment, analysis of cell survival using clonogenic assay showed a significant decrease in cell growth in both cell lines. Ru(II) complex also caused G 1 cell cycle arrest of ~13% in both cell lines. The highest percentage of apoptotic MIA PaCa-2 cells was obtained 48 h after treatment. In addition, the intracellular level of reactive oxygen species (ROS) was significantly increased, whereas cell migration was reduced in both cell lines. Summarized, Ru(II)complex demonstrates antitumor properties mediated by increased oxidative stress and also implies the antimetastatic potential, which deserves further study.",
publisher = "Belgrade : Faculty of Chemistry : Serbian Biochemical Society",
journal = "Serbian Biochemical Society : 11th conference - "Amazing Biochemistry" : proceedings ; September 22-23, 2022; Novi Sad, Serbia",
title = "ROS-mediated proapoptotic antitumor effects of Ru(II) complex on pancreatic cancer cells",
pages = "155",
url = "https://hdl.handle.net/21.15107/rcub_vinar_11011"
}
Čolakov, K., Nešić, M. D., Matijević, M., Stepić, M., Petković, M., Korićanac, L.,& Žakula, J.. (2022). ROS-mediated proapoptotic antitumor effects of Ru(II) complex on pancreatic cancer cells. in Serbian Biochemical Society : 11th conference - "Amazing Biochemistry" : proceedings ; September 22-23, 2022; Novi Sad, Serbia
Belgrade : Faculty of Chemistry : Serbian Biochemical Society., 155.
https://hdl.handle.net/21.15107/rcub_vinar_11011
Čolakov K, Nešić MD, Matijević M, Stepić M, Petković M, Korićanac L, Žakula J. ROS-mediated proapoptotic antitumor effects of Ru(II) complex on pancreatic cancer cells. in Serbian Biochemical Society : 11th conference - "Amazing Biochemistry" : proceedings ; September 22-23, 2022; Novi Sad, Serbia. 2022;:155.
https://hdl.handle.net/21.15107/rcub_vinar_11011 .
Čolakov, Katarina, Nešić, Maja D., Matijević, Milica, Stepić, Milutin, Petković, Marijana, Korićanac, Lela, Žakula, Jelena, "ROS-mediated proapoptotic antitumor effects of Ru(II) complex on pancreatic cancer cells" in Serbian Biochemical Society : 11th conference - "Amazing Biochemistry" : proceedings ; September 22-23, 2022; Novi Sad, Serbia (2022):155,
https://hdl.handle.net/21.15107/rcub_vinar_11011 .

Blue light-enhanced cytotoxic activity of nitrogen-doped TiO2 nanoparticles in human cervical cancer cells

Matijević, Milica; Petković, Marijana; Stepić, Milutin; Nešić, Maja

(2021)

TY  - CONF
AU  - Matijević, Milica
AU  - Petković, Marijana
AU  - Stepić, Milutin
AU  - Nešić, Maja
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12745
AB  - We have studied the cytotoxicity and phototoxicity of nitrogen-doped TiO2 (N-TiO2) nanoparticles (NPs) of the anatase crystal form for a possible human cervical (HeLa) cancer therapy. TiO2 is biocompatible with living structures (a) and its electrons in the valence band can be excited under ultraviolet (UV) light irradiation to produce reactive oxygen species and kill cancer cells. On the other hand, UV light is harmful and its penetration depth is short, which hinders its applications as a photosensitizer. Thus, we have chosen doping of TiO2 with nitrogen, since it was already shown that N-doping shifts the absorbance towards the visible region and enables photoactivation of the TiO2 with visible light, whereas the biocompatibility is preserved. (b) To assess the biocompatibility of N-TiO2 with the cancer cells, we have treated the HeLa cell line with three different concentrations of N-TiO2 NPs suspensions. After 24h of incubation in the dark, we have observed significant cytotoxicity in samples treated with concentration of 100 μg mL-1 of N-TiO2 NPs, whereas no significant cytotoxicity of the concentrations ≤50 μg mL-1 was detected. Hence, we have selected the treatment of 50 μg mL-1 of the N-TiO2 NPs for phototoxicity and cell imaging. Given that the N-TiO2 absorbs in the region of 400-450 nm, we have examined the viability of the HeLa cancer cell line upon the N-TiO2 treatment followed by continuous blue light irradiation (420 nm, 10 μW) for 15 minutes. The survival fraction of the cells treated with N-TiO2 NPs decreased significantly upon blue light irradiation. The intracellular distribution of N-TiO2 NPs was examined by laser scanning confocal microscopy. Most of the cells survived the treatment after 24h, and the agglomerates of N-TiO2 NPs were distributed mainly inside the cancer cells. The results of viability in the dark show that N-TiO2 NPs are not toxic for HeLa cells in the lower concentrations, and the evidence of cellular uptake points towards their biocompatibility. Furthermore, we have shown that it is feasible to induce cells’ phototoxicity upon treatment with N-TiO2 NPs and blue light irradiation.
C3  - 28th Young Research Fellow Meeting
T1  - Blue light-enhanced cytotoxic activity of nitrogen-doped TiO2 nanoparticles in human cervical cancer cells
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12745
ER  - 
@conference{
author = "Matijević, Milica and Petković, Marijana and Stepić, Milutin and Nešić, Maja",
year = "2021",
abstract = "We have studied the cytotoxicity and phototoxicity of nitrogen-doped TiO2 (N-TiO2) nanoparticles (NPs) of the anatase crystal form for a possible human cervical (HeLa) cancer therapy. TiO2 is biocompatible with living structures (a) and its electrons in the valence band can be excited under ultraviolet (UV) light irradiation to produce reactive oxygen species and kill cancer cells. On the other hand, UV light is harmful and its penetration depth is short, which hinders its applications as a photosensitizer. Thus, we have chosen doping of TiO2 with nitrogen, since it was already shown that N-doping shifts the absorbance towards the visible region and enables photoactivation of the TiO2 with visible light, whereas the biocompatibility is preserved. (b) To assess the biocompatibility of N-TiO2 with the cancer cells, we have treated the HeLa cell line with three different concentrations of N-TiO2 NPs suspensions. After 24h of incubation in the dark, we have observed significant cytotoxicity in samples treated with concentration of 100 μg mL-1 of N-TiO2 NPs, whereas no significant cytotoxicity of the concentrations ≤50 μg mL-1 was detected. Hence, we have selected the treatment of 50 μg mL-1 of the N-TiO2 NPs for phototoxicity and cell imaging. Given that the N-TiO2 absorbs in the region of 400-450 nm, we have examined the viability of the HeLa cancer cell line upon the N-TiO2 treatment followed by continuous blue light irradiation (420 nm, 10 μW) for 15 minutes. The survival fraction of the cells treated with N-TiO2 NPs decreased significantly upon blue light irradiation. The intracellular distribution of N-TiO2 NPs was examined by laser scanning confocal microscopy. Most of the cells survived the treatment after 24h, and the agglomerates of N-TiO2 NPs were distributed mainly inside the cancer cells. The results of viability in the dark show that N-TiO2 NPs are not toxic for HeLa cells in the lower concentrations, and the evidence of cellular uptake points towards their biocompatibility. Furthermore, we have shown that it is feasible to induce cells’ phototoxicity upon treatment with N-TiO2 NPs and blue light irradiation.",
journal = "28th Young Research Fellow Meeting",
title = "Blue light-enhanced cytotoxic activity of nitrogen-doped TiO2 nanoparticles in human cervical cancer cells",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12745"
}
Matijević, M., Petković, M., Stepić, M.,& Nešić, M.. (2021). Blue light-enhanced cytotoxic activity of nitrogen-doped TiO2 nanoparticles in human cervical cancer cells. in 28th Young Research Fellow Meeting.
https://hdl.handle.net/21.15107/rcub_vinar_12745
Matijević M, Petković M, Stepić M, Nešić M. Blue light-enhanced cytotoxic activity of nitrogen-doped TiO2 nanoparticles in human cervical cancer cells. in 28th Young Research Fellow Meeting. 2021;.
https://hdl.handle.net/21.15107/rcub_vinar_12745 .
Matijević, Milica, Petković, Marijana, Stepić, Milutin, Nešić, Maja, "Blue light-enhanced cytotoxic activity of nitrogen-doped TiO2 nanoparticles in human cervical cancer cells" in 28th Young Research Fellow Meeting (2021),
https://hdl.handle.net/21.15107/rcub_vinar_12745 .

Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles

Matijević, Milica; Žakula, Jelena; Korićanac, Lela; Radoičić, Marija B.; Liang, Xinyue; Mi, Lan; Filipović Tričković, Jelena G.; Valenta-Šobot, Ana; Stanković, Maja N.; Nakarada, Đura; Mojović, Miloš; Petković, Marijana; Stepić, Milutin; Nešić, Maja D.

(2021)

TY  - JOUR
AU  - Matijević, Milica
AU  - Žakula, Jelena
AU  - Korićanac, Lela
AU  - Radoičić, Marija B.
AU  - Liang, Xinyue
AU  - Mi, Lan
AU  - Filipović Tričković, Jelena G.
AU  - Valenta-Šobot, Ana
AU  - Stanković, Maja N.
AU  - Nakarada, Đura
AU  - Mojović, Miloš
AU  - Petković, Marijana
AU  - Stepić, Milutin
AU  - Nešić, Maja D.
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/9908
AB  - In this study, C-doped TiO2 nanoparticles (C-TiO2) were prepared and tested as a photosensitizer for visible-light-driven photodynamic therapy against cervical cancer cells (HeLa). X-ray diffraction and Transmission Electron Microscopy confirmed the anatase form of nanoparticles, spherical shape, and size distribution from 5 to 15 nm. Ultraviolet–visible light spectroscopy showed that C doping of TiO2 enhances the optical absorption in the visible light range caused by a bandgap narrowing. The photo-cytotoxic activity of C-TiO2 was investigated in vitro against HeLa cells. The lack of dark cytotoxicity indicates good biocompatibility of C-TiO2. In contrast, a combination with blue light significantly reduced the survival of HeLa cells: illumination only decreased cell viability by 30% (15 min of illumination, 120 µW power), and 60% when HeLa cells were preincubated with C-TiO2. We have also confirmed blue light-induced C-TiO2-catalyzed generation of reactive oxygen species in vitro and intracellularly. Oxidative stress triggered by C-TiO2/blue light was the leading cause of HeLa cell death. Fluorescent labeling of treated HeLa cells showed distinct morphological changes after the C-TiO2/blue light treatment. Unlike blue light illumination, which caused the appearance of large necrotic cells with deformed nuclei, cytoplasm swelling, and membrane blebbing, a combination of C-TiO2/blue light leads to controlled cell death, thus providing a better outcome of local anticancer therapy.
T2  - Photochemical and Photobiological Sciences
T1  - Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles
VL  - 20
IS  - 8
SP  - 1087
EP  - 1098
DO  - 10.1007/s43630-021-00082-2
ER  - 
@article{
author = "Matijević, Milica and Žakula, Jelena and Korićanac, Lela and Radoičić, Marija B. and Liang, Xinyue and Mi, Lan and Filipović Tričković, Jelena G. and Valenta-Šobot, Ana and Stanković, Maja N. and Nakarada, Đura and Mojović, Miloš and Petković, Marijana and Stepić, Milutin and Nešić, Maja D.",
year = "2021",
abstract = "In this study, C-doped TiO2 nanoparticles (C-TiO2) were prepared and tested as a photosensitizer for visible-light-driven photodynamic therapy against cervical cancer cells (HeLa). X-ray diffraction and Transmission Electron Microscopy confirmed the anatase form of nanoparticles, spherical shape, and size distribution from 5 to 15 nm. Ultraviolet–visible light spectroscopy showed that C doping of TiO2 enhances the optical absorption in the visible light range caused by a bandgap narrowing. The photo-cytotoxic activity of C-TiO2 was investigated in vitro against HeLa cells. The lack of dark cytotoxicity indicates good biocompatibility of C-TiO2. In contrast, a combination with blue light significantly reduced the survival of HeLa cells: illumination only decreased cell viability by 30% (15 min of illumination, 120 µW power), and 60% when HeLa cells were preincubated with C-TiO2. We have also confirmed blue light-induced C-TiO2-catalyzed generation of reactive oxygen species in vitro and intracellularly. Oxidative stress triggered by C-TiO2/blue light was the leading cause of HeLa cell death. Fluorescent labeling of treated HeLa cells showed distinct morphological changes after the C-TiO2/blue light treatment. Unlike blue light illumination, which caused the appearance of large necrotic cells with deformed nuclei, cytoplasm swelling, and membrane blebbing, a combination of C-TiO2/blue light leads to controlled cell death, thus providing a better outcome of local anticancer therapy.",
journal = "Photochemical and Photobiological Sciences",
title = "Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles",
volume = "20",
number = "8",
pages = "1087-1098",
doi = "10.1007/s43630-021-00082-2"
}
Matijević, M., Žakula, J., Korićanac, L., Radoičić, M. B., Liang, X., Mi, L., Filipović Tričković, J. G., Valenta-Šobot, A., Stanković, M. N., Nakarada, Đ., Mojović, M., Petković, M., Stepić, M.,& Nešić, M. D.. (2021). Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles. in Photochemical and Photobiological Sciences, 20(8), 1087-1098.
https://doi.org/10.1007/s43630-021-00082-2
Matijević M, Žakula J, Korićanac L, Radoičić MB, Liang X, Mi L, Filipović Tričković JG, Valenta-Šobot A, Stanković MN, Nakarada Đ, Mojović M, Petković M, Stepić M, Nešić MD. Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles. in Photochemical and Photobiological Sciences. 2021;20(8):1087-1098.
doi:10.1007/s43630-021-00082-2 .
Matijević, Milica, Žakula, Jelena, Korićanac, Lela, Radoičić, Marija B., Liang, Xinyue, Mi, Lan, Filipović Tričković, Jelena G., Valenta-Šobot, Ana, Stanković, Maja N., Nakarada, Đura, Mojović, Miloš, Petković, Marijana, Stepić, Milutin, Nešić, Maja D., "Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles" in Photochemical and Photobiological Sciences, 20, no. 8 (2021):1087-1098,
https://doi.org/10.1007/s43630-021-00082-2 . .
4
3

Antitumor effect of Ru(II) complex on A375 and HeLa cell growth, migration and adhesion ability

Nešić, Maja D.; Matijević, Milica; Stepić, Milutin; Petković, Marijana; Korićanac, Lela

(2021)

TY  - CONF
AU  - Nešić, Maja D.
AU  - Matijević, Milica
AU  - Stepić, Milutin
AU  - Petković, Marijana
AU  - Korićanac, Lela
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12467
AB  - Platinum-based complexes represent the mainstay of treatment for various cancer types. However, their usage is often restricted by numerous side effects or intrinsic and acquired resistance. Therefore, significant research efforts have focused on developing therapeutics based on other transition metals, such as ruthenium 1,2. In this study, effects of transition metal complex, cis-dichlorobis (2,2ʹ-bipyridyl-4,4ʹ-dicarboxylic acid)ruthenium(II) (Ru(II) complex) were analyzed on A375 human melanoma and HeLa cell growth, adhesion ability andmigration. Cell viability assay indicated significant antitumor activity of Ru(II) complex on A375 (~60% of control) up to 72 h after treatment, but not on HeLa cells. However, analysis by clonogenic assay showed that growth of both cell lines was decreased 7 days after treatment. Growth inhibition was followed by G1 phase cell cycle arrest (5–10% G1 increase for A375 and 5–8% for HeLa cells compared to control). Moreover, Ru(II) complex increased adhesivity of A375 and HeLa cells by 11 and 16 % respectively and decreased cell migration, as shown by scratch assay. The obtained results indicate that the analyzed Ru(II) complex is a promising metallodrug, as itinduced growth inhibition of A375 and HeLa cells through induction of G1 arrest and decreased metastatic potential of these cells through the increase ofadhesivity and decrease of cell migration.
C3  - Serbian Biochemical Society Tenth Conference : “Biochemical Insights into Molecular Mechanisms”
T1  - Antitumor effect of Ru(II) complex on A375 and HeLa cell growth, migration and adhesion ability
SP  - 76
EP  - 76
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12467
ER  - 
@conference{
author = "Nešić, Maja D. and Matijević, Milica and Stepić, Milutin and Petković, Marijana and Korićanac, Lela",
year = "2021",
abstract = "Platinum-based complexes represent the mainstay of treatment for various cancer types. However, their usage is often restricted by numerous side effects or intrinsic and acquired resistance. Therefore, significant research efforts have focused on developing therapeutics based on other transition metals, such as ruthenium 1,2. In this study, effects of transition metal complex, cis-dichlorobis (2,2ʹ-bipyridyl-4,4ʹ-dicarboxylic acid)ruthenium(II) (Ru(II) complex) were analyzed on A375 human melanoma and HeLa cell growth, adhesion ability andmigration. Cell viability assay indicated significant antitumor activity of Ru(II) complex on A375 (~60% of control) up to 72 h after treatment, but not on HeLa cells. However, analysis by clonogenic assay showed that growth of both cell lines was decreased 7 days after treatment. Growth inhibition was followed by G1 phase cell cycle arrest (5–10% G1 increase for A375 and 5–8% for HeLa cells compared to control). Moreover, Ru(II) complex increased adhesivity of A375 and HeLa cells by 11 and 16 % respectively and decreased cell migration, as shown by scratch assay. The obtained results indicate that the analyzed Ru(II) complex is a promising metallodrug, as itinduced growth inhibition of A375 and HeLa cells through induction of G1 arrest and decreased metastatic potential of these cells through the increase ofadhesivity and decrease of cell migration.",
journal = "Serbian Biochemical Society Tenth Conference : “Biochemical Insights into Molecular Mechanisms”",
title = "Antitumor effect of Ru(II) complex on A375 and HeLa cell growth, migration and adhesion ability",
pages = "76-76",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12467"
}
Nešić, M. D., Matijević, M., Stepić, M., Petković, M.,& Korićanac, L.. (2021). Antitumor effect of Ru(II) complex on A375 and HeLa cell growth, migration and adhesion ability. in Serbian Biochemical Society Tenth Conference : “Biochemical Insights into Molecular Mechanisms”, 76-76.
https://hdl.handle.net/21.15107/rcub_vinar_12467
Nešić MD, Matijević M, Stepić M, Petković M, Korićanac L. Antitumor effect of Ru(II) complex on A375 and HeLa cell growth, migration and adhesion ability. in Serbian Biochemical Society Tenth Conference : “Biochemical Insights into Molecular Mechanisms”. 2021;:76-76.
https://hdl.handle.net/21.15107/rcub_vinar_12467 .
Nešić, Maja D., Matijević, Milica, Stepić, Milutin, Petković, Marijana, Korićanac, Lela, "Antitumor effect of Ru(II) complex on A375 and HeLa cell growth, migration and adhesion ability" in Serbian Biochemical Society Tenth Conference : “Biochemical Insights into Molecular Mechanisms” (2021):76-76,
https://hdl.handle.net/21.15107/rcub_vinar_12467 .

Visible light-responsiveness of the nanocarrier/drug complex based on the TiO2 nanoparticles and Ru complex

Matijević, Milica; Stepić, Milutin; Radojičić, M.; Petković, M.; Nešić, M. D.

(Belgrade : Institute of Physics Belgrade, 2021)

TY  - CONF
AU  - Matijević, Milica
AU  - Stepić, Milutin
AU  - Radojičić, M.
AU  - Petković, M.
AU  - Nešić, M. D.
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/10910
AB  - TiO2 nanoparticles (NPs) have great potential for implementing photodynamic therapy (PDT) as a part of drug delivery therapeutical systems. PDT is an emerging anti-cancer therapy that involves the administration of photosensitizer (PS), which undergoes reversible changes upon light exposure. Next, PS can release a cytostatic drugand/or transfer its energy to molecular oxygen, generating reactive oxygen species (ROS), consequentlyleading to cancer cell ablation [1]. In this work, we assessed photocytotoxicity to the HeLa cell line of the nanocarrier/drug complexes– nanocomposite systems (NCSs) made of different types of carriers, TiO2 NPs, for the delivery of Ru complex (cis-dichlorobis (2,2'-bipyridyl-4,4'-dicarboxylic acid)ruthenium(II). One tested NCS consists of colloid TiO2 NPs, whereas the other consists of the TiO2prolatenanospheroids (PNSs). Previously in our work, both TiO2 NPs demonstrated good biocompatibility in the dark [2,3], whereas the Ru complex exhibited notable anti-proliferative, genotoxic, and antitumor effects [4].AsTiO2 NPs are photo-active in the UV range, and the Ru complex absorbs in both UV and visible spectrum [3],herein, we havedetermined the optical bandgaps of the synthesized NCSs withTauc’s plot. Calculated bandgaps of the synthesized NCSs proved that the Ru complex extends the responsiveness of TiO2 to visible light while acts as a medicament in photo-active NCSs, allowing the absorption of the NCSs in the visible range. Thus, we have examined the photocytotoxicity of the combined treatment of the HeLa cells with NCSs and visible light. The preliminary results show that visible light, which is not harmful when applied alone to the cells, can effectively induce a cytotoxic effect in the combined therapy with the NCSs.
PB  - Belgrade : Institute of Physics Belgrade
C3  - PHOTONICA2021 : 8th International School and Conference on Photonics and HEMMAGINERO workshop : Abstracts of Tutorial, Keynote, Invited Lectures, Progress Reports and Contributed Papers; August 23-27, 2021; Belgrade
T1  - Visible light-responsiveness of the nanocarrier/drug complex based on the TiO2 nanoparticles and Ru complex
SP  - 109
UR  - https://hdl.handle.net/21.15107/rcub_vinar_10910
ER  - 
@conference{
author = "Matijević, Milica and Stepić, Milutin and Radojičić, M. and Petković, M. and Nešić, M. D.",
year = "2021",
abstract = "TiO2 nanoparticles (NPs) have great potential for implementing photodynamic therapy (PDT) as a part of drug delivery therapeutical systems. PDT is an emerging anti-cancer therapy that involves the administration of photosensitizer (PS), which undergoes reversible changes upon light exposure. Next, PS can release a cytostatic drugand/or transfer its energy to molecular oxygen, generating reactive oxygen species (ROS), consequentlyleading to cancer cell ablation [1]. In this work, we assessed photocytotoxicity to the HeLa cell line of the nanocarrier/drug complexes– nanocomposite systems (NCSs) made of different types of carriers, TiO2 NPs, for the delivery of Ru complex (cis-dichlorobis (2,2'-bipyridyl-4,4'-dicarboxylic acid)ruthenium(II). One tested NCS consists of colloid TiO2 NPs, whereas the other consists of the TiO2prolatenanospheroids (PNSs). Previously in our work, both TiO2 NPs demonstrated good biocompatibility in the dark [2,3], whereas the Ru complex exhibited notable anti-proliferative, genotoxic, and antitumor effects [4].AsTiO2 NPs are photo-active in the UV range, and the Ru complex absorbs in both UV and visible spectrum [3],herein, we havedetermined the optical bandgaps of the synthesized NCSs withTauc’s plot. Calculated bandgaps of the synthesized NCSs proved that the Ru complex extends the responsiveness of TiO2 to visible light while acts as a medicament in photo-active NCSs, allowing the absorption of the NCSs in the visible range. Thus, we have examined the photocytotoxicity of the combined treatment of the HeLa cells with NCSs and visible light. The preliminary results show that visible light, which is not harmful when applied alone to the cells, can effectively induce a cytotoxic effect in the combined therapy with the NCSs.",
publisher = "Belgrade : Institute of Physics Belgrade",
journal = "PHOTONICA2021 : 8th International School and Conference on Photonics and HEMMAGINERO workshop : Abstracts of Tutorial, Keynote, Invited Lectures, Progress Reports and Contributed Papers; August 23-27, 2021; Belgrade",
title = "Visible light-responsiveness of the nanocarrier/drug complex based on the TiO2 nanoparticles and Ru complex",
pages = "109",
url = "https://hdl.handle.net/21.15107/rcub_vinar_10910"
}
Matijević, M., Stepić, M., Radojičić, M., Petković, M.,& Nešić, M. D.. (2021). Visible light-responsiveness of the nanocarrier/drug complex based on the TiO2 nanoparticles and Ru complex. in PHOTONICA2021 : 8th International School and Conference on Photonics and HEMMAGINERO workshop : Abstracts of Tutorial, Keynote, Invited Lectures, Progress Reports and Contributed Papers; August 23-27, 2021; Belgrade
Belgrade : Institute of Physics Belgrade., 109.
https://hdl.handle.net/21.15107/rcub_vinar_10910
Matijević M, Stepić M, Radojičić M, Petković M, Nešić MD. Visible light-responsiveness of the nanocarrier/drug complex based on the TiO2 nanoparticles and Ru complex. in PHOTONICA2021 : 8th International School and Conference on Photonics and HEMMAGINERO workshop : Abstracts of Tutorial, Keynote, Invited Lectures, Progress Reports and Contributed Papers; August 23-27, 2021; Belgrade. 2021;:109.
https://hdl.handle.net/21.15107/rcub_vinar_10910 .
Matijević, Milica, Stepić, Milutin, Radojičić, M., Petković, M., Nešić, M. D., "Visible light-responsiveness of the nanocarrier/drug complex based on the TiO2 nanoparticles and Ru complex" in PHOTONICA2021 : 8th International School and Conference on Photonics and HEMMAGINERO workshop : Abstracts of Tutorial, Keynote, Invited Lectures, Progress Reports and Contributed Papers; August 23-27, 2021; Belgrade (2021):109,
https://hdl.handle.net/21.15107/rcub_vinar_10910 .

Biocompatibility of TiO2 prolate nanospheroids as a potential photosenzitizer in therapy of cancer

Matijević, Milica; Nakarada, Đura; Liang, Xinyue; Korićanac, Lela; Rajsiglova, Lenka; Vannucci, Luca; Nešić, Maja D.; Vranješ, Mila; Mojović, Miloš D.; Mi, Lan; Estrela-Lopis, Irina; Böttner, Julia; Šaponjić, Zoran; Petković, Marijana; Stepić, Milutin

(2020)

TY  - JOUR
AU  - Matijević, Milica
AU  - Nakarada, Đura
AU  - Liang, Xinyue
AU  - Korićanac, Lela
AU  - Rajsiglova, Lenka
AU  - Vannucci, Luca
AU  - Nešić, Maja D.
AU  - Vranješ, Mila
AU  - Mojović, Miloš D.
AU  - Mi, Lan
AU  - Estrela-Lopis, Irina
AU  - Böttner, Julia
AU  - Šaponjić, Zoran
AU  - Petković, Marijana
AU  - Stepić, Milutin
PY  - 2020
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/9058
AB  - TiO2 prolatenanospheroids (PNSs) may be photosensitizers (PSs), which act by catalyzation of hydroxyl radical (∙OH) formation upon light illumination. ∙OH might, in turn, contribute to killing of cancer cells. On the other hand, there is great concern about toxicity in the dark of TiO2 nanoparticles in general. In this work, we have investigated the biocompatibility of TiO2 PNSs of the anatase crystal form (length between 100 and 300 nm and width 50 nm) in the dark with immune cells and light-induced cytotoxicity on several cancer cell lines. The effects of the treatment of different cell lines with several concentrations of TiO2 PNSs suspensions showed the specifics of cells’ viability and the intracellular localization. The results of in vitro studies obtained by cytotoxicity assays adjusted to individual cell lines’ metabolism point towards the biocompatibility of TiO2 PNSs at low and moderate concentrations in the dark, which neither kill the cells, nor induce activation of the immune system cells. Laser scanning confocal microscopy revealed that PNSs are taken up by cells, and insight into the intracellular distribution was obtained in this study.
T2  - Journal of Nanoparticle Research
T1  - Biocompatibility of TiO2 prolate nanospheroids as a potential photosenzitizer in therapy of cancer
VL  - 22
IS  - 7
SP  - 175
DO  - 10.1007/s11051-020-04899-3
ER  - 
@article{
author = "Matijević, Milica and Nakarada, Đura and Liang, Xinyue and Korićanac, Lela and Rajsiglova, Lenka and Vannucci, Luca and Nešić, Maja D. and Vranješ, Mila and Mojović, Miloš D. and Mi, Lan and Estrela-Lopis, Irina and Böttner, Julia and Šaponjić, Zoran and Petković, Marijana and Stepić, Milutin",
year = "2020",
abstract = "TiO2 prolatenanospheroids (PNSs) may be photosensitizers (PSs), which act by catalyzation of hydroxyl radical (∙OH) formation upon light illumination. ∙OH might, in turn, contribute to killing of cancer cells. On the other hand, there is great concern about toxicity in the dark of TiO2 nanoparticles in general. In this work, we have investigated the biocompatibility of TiO2 PNSs of the anatase crystal form (length between 100 and 300 nm and width 50 nm) in the dark with immune cells and light-induced cytotoxicity on several cancer cell lines. The effects of the treatment of different cell lines with several concentrations of TiO2 PNSs suspensions showed the specifics of cells’ viability and the intracellular localization. The results of in vitro studies obtained by cytotoxicity assays adjusted to individual cell lines’ metabolism point towards the biocompatibility of TiO2 PNSs at low and moderate concentrations in the dark, which neither kill the cells, nor induce activation of the immune system cells. Laser scanning confocal microscopy revealed that PNSs are taken up by cells, and insight into the intracellular distribution was obtained in this study.",
journal = "Journal of Nanoparticle Research",
title = "Biocompatibility of TiO2 prolate nanospheroids as a potential photosenzitizer in therapy of cancer",
volume = "22",
number = "7",
pages = "175",
doi = "10.1007/s11051-020-04899-3"
}
Matijević, M., Nakarada, Đ., Liang, X., Korićanac, L., Rajsiglova, L., Vannucci, L., Nešić, M. D., Vranješ, M., Mojović, M. D., Mi, L., Estrela-Lopis, I., Böttner, J., Šaponjić, Z., Petković, M.,& Stepić, M.. (2020). Biocompatibility of TiO2 prolate nanospheroids as a potential photosenzitizer in therapy of cancer. in Journal of Nanoparticle Research, 22(7), 175.
https://doi.org/10.1007/s11051-020-04899-3
Matijević M, Nakarada Đ, Liang X, Korićanac L, Rajsiglova L, Vannucci L, Nešić MD, Vranješ M, Mojović MD, Mi L, Estrela-Lopis I, Böttner J, Šaponjić Z, Petković M, Stepić M. Biocompatibility of TiO2 prolate nanospheroids as a potential photosenzitizer in therapy of cancer. in Journal of Nanoparticle Research. 2020;22(7):175.
doi:10.1007/s11051-020-04899-3 .
Matijević, Milica, Nakarada, Đura, Liang, Xinyue, Korićanac, Lela, Rajsiglova, Lenka, Vannucci, Luca, Nešić, Maja D., Vranješ, Mila, Mojović, Miloš D., Mi, Lan, Estrela-Lopis, Irina, Böttner, Julia, Šaponjić, Zoran, Petković, Marijana, Stepić, Milutin, "Biocompatibility of TiO2 prolate nanospheroids as a potential photosenzitizer in therapy of cancer" in Journal of Nanoparticle Research, 22, no. 7 (2020):175,
https://doi.org/10.1007/s11051-020-04899-3 . .
5
1
6

Application of oxidation processes in the purification of wastewaters from phenolic compounds

Matijević, Milica; Stanković, Maja N.; Krstić, Nenad S.; Nikolić, Milica G.; Kostić, Danijela A.

(2020)

TY  - JOUR
AU  - Matijević, Milica
AU  - Stanković, Maja N.
AU  - Krstić, Nenad S.
AU  - Nikolić, Milica G.
AU  - Kostić, Danijela A.
PY  - 2020
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/9665
AB  - Natural phenolic compounds are significant component of the human diet, as they are present in fruits and vegetables, and they have very important biological activity in the living organisms. Because of their structure, they are subject of numerous oxidation processes, such as autoxidation, but are easily to oxidize in presence of various oxidizing agents and enzymes. Many authors have been investigating phenolic oxidation processes, and have successfully identified their pathways and a significant number of intermediates and products generated by these processes. Also, particular attention has been made to the effects of these processes on food quality and other biological processes in living organisms. Phenols are persistent pollutants of water systems from various agricultural activities and industrial wastewater discharges. It is known that the presence of phenolic compounds in water supplies and industrial effluents directly affects natural processes in the environment due to their toxicity and natural ability to decompose. This property, to easily oxidize and, as a result of it, to mineralize, is practically useful for the treatment of the wastewaters, so it is of global concern to manage the best technology to remove phenols and other organic pollutants, assisted with the oxidation processes. In the aspect of treatment of wastewaters polluted with phenols, we reviewed oxidative processes such as autoxidation, enzyme-catalyzed oxidation, photo-oxidation, electrochemical oxidation and oxidation by Fenton's reagent and, based on the literature data, we presented advantages and disadvantages of these processes compared to each other. © 2020 Editura Academiei Romane. All rights reserved.
T2  - Revue Roumaine de Chimie
T1  - Application of oxidation processes in the purification of wastewaters from phenolic compounds
VL  - 65
IS  - 4
SP  - 313
EP  - 327
DO  - 10.33224/rrch.2020.65.4.01
ER  - 
@article{
author = "Matijević, Milica and Stanković, Maja N. and Krstić, Nenad S. and Nikolić, Milica G. and Kostić, Danijela A.",
year = "2020",
abstract = "Natural phenolic compounds are significant component of the human diet, as they are present in fruits and vegetables, and they have very important biological activity in the living organisms. Because of their structure, they are subject of numerous oxidation processes, such as autoxidation, but are easily to oxidize in presence of various oxidizing agents and enzymes. Many authors have been investigating phenolic oxidation processes, and have successfully identified their pathways and a significant number of intermediates and products generated by these processes. Also, particular attention has been made to the effects of these processes on food quality and other biological processes in living organisms. Phenols are persistent pollutants of water systems from various agricultural activities and industrial wastewater discharges. It is known that the presence of phenolic compounds in water supplies and industrial effluents directly affects natural processes in the environment due to their toxicity and natural ability to decompose. This property, to easily oxidize and, as a result of it, to mineralize, is practically useful for the treatment of the wastewaters, so it is of global concern to manage the best technology to remove phenols and other organic pollutants, assisted with the oxidation processes. In the aspect of treatment of wastewaters polluted with phenols, we reviewed oxidative processes such as autoxidation, enzyme-catalyzed oxidation, photo-oxidation, electrochemical oxidation and oxidation by Fenton's reagent and, based on the literature data, we presented advantages and disadvantages of these processes compared to each other. © 2020 Editura Academiei Romane. All rights reserved.",
journal = "Revue Roumaine de Chimie",
title = "Application of oxidation processes in the purification of wastewaters from phenolic compounds",
volume = "65",
number = "4",
pages = "313-327",
doi = "10.33224/rrch.2020.65.4.01"
}
Matijević, M., Stanković, M. N., Krstić, N. S., Nikolić, M. G.,& Kostić, D. A.. (2020). Application of oxidation processes in the purification of wastewaters from phenolic compounds. in Revue Roumaine de Chimie, 65(4), 313-327.
https://doi.org/10.33224/rrch.2020.65.4.01
Matijević M, Stanković MN, Krstić NS, Nikolić MG, Kostić DA. Application of oxidation processes in the purification of wastewaters from phenolic compounds. in Revue Roumaine de Chimie. 2020;65(4):313-327.
doi:10.33224/rrch.2020.65.4.01 .
Matijević, Milica, Stanković, Maja N., Krstić, Nenad S., Nikolić, Milica G., Kostić, Danijela A., "Application of oxidation processes in the purification of wastewaters from phenolic compounds" in Revue Roumaine de Chimie, 65, no. 4 (2020):313-327,
https://doi.org/10.33224/rrch.2020.65.4.01 . .

Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy

Matijević, Milica; Nešić, Maja; Stepić, Milutin; Radoičić, Marija B.; Šaponjić, Zoran; Petković, Marijana

(2018)

TY  - JOUR
AU  - Matijević, Milica
AU  - Nešić, Maja
AU  - Stepić, Milutin
AU  - Radoičić, Marija B.
AU  - Šaponjić, Zoran
AU  - Petković, Marijana
PY  - 2018
UR  - http://link.springer.com/10.1007/s11082-018-1495-z
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/7697
AB  - Photodynamic therapy implies a combined use of a photosensitizing medicament and low-intensity light to cause selective damage to the target tissue—tumor. As potential medicament, we use Ru(II)(dcbpy)2Cl2complex, and in order to achieve better photosensitization properties, the Ru complex was attached to the nano carrier—TiO2nanoparticles. Additionally, this nanocomposite system was encapsulated in the phospholipid vesicles, which could be classified as small unilamellar vesicles, based on the technique of production. The complex-release tests were performed under light illumination, at pH 5, characteristic for tumor cells` interior and compared with the release pattern at pH 7, characteristic for the serum, i.e. physiological solution.
T2  - Optical and Quantum Electronics
T1  - Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy
VL  - 50
IS  - 6
SP  - 232
DO  - 10.1007/s11082-018-1495-z
ER  - 
@article{
author = "Matijević, Milica and Nešić, Maja and Stepić, Milutin and Radoičić, Marija B. and Šaponjić, Zoran and Petković, Marijana",
year = "2018",
abstract = "Photodynamic therapy implies a combined use of a photosensitizing medicament and low-intensity light to cause selective damage to the target tissue—tumor. As potential medicament, we use Ru(II)(dcbpy)2Cl2complex, and in order to achieve better photosensitization properties, the Ru complex was attached to the nano carrier—TiO2nanoparticles. Additionally, this nanocomposite system was encapsulated in the phospholipid vesicles, which could be classified as small unilamellar vesicles, based on the technique of production. The complex-release tests were performed under light illumination, at pH 5, characteristic for tumor cells` interior and compared with the release pattern at pH 7, characteristic for the serum, i.e. physiological solution.",
journal = "Optical and Quantum Electronics",
title = "Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy",
volume = "50",
number = "6",
pages = "232",
doi = "10.1007/s11082-018-1495-z"
}
Matijević, M., Nešić, M., Stepić, M., Radoičić, M. B., Šaponjić, Z.,& Petković, M.. (2018). Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy. in Optical and Quantum Electronics, 50(6), 232.
https://doi.org/10.1007/s11082-018-1495-z
Matijević M, Nešić M, Stepić M, Radoičić MB, Šaponjić Z, Petković M. Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy. in Optical and Quantum Electronics. 2018;50(6):232.
doi:10.1007/s11082-018-1495-z .
Matijević, Milica, Nešić, Maja, Stepić, Milutin, Radoičić, Marija B., Šaponjić, Zoran, Petković, Marijana, "Light controllable TiO2-Ru nanocomposite system encapsulated in phospholipid unilamellar vesicles for anti-cancer photodynamic therapy" in Optical and Quantum Electronics, 50, no. 6 (2018):232,
https://doi.org/10.1007/s11082-018-1495-z . .
2
1
1

Inorganic Nanoparticles In Biology: Drug Carriers And Auxiliary Tools In Bioimaging And Bioanalytics

Matijević, Milica; Popović, Iva A.; Stepić, Milutin; Nešić, Maja D.; Radoičić, Marija B.; Stanković, Maja; Šaponjić, Zoran; Petković, Marijana

(2018)

TY  - JOUR
AU  - Matijević, Milica
AU  - Popović, Iva A.
AU  - Stepić, Milutin
AU  - Nešić, Maja D.
AU  - Radoičić, Marija B.
AU  - Stanković, Maja
AU  - Šaponjić, Zoran
AU  - Petković, Marijana
PY  - 2018
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/9062
AB  - Among various nano-scaled materials composed from a spectrum of chemical compounds, inorganic nanoparticles are very attractive due to their physico-chemical properties, as well as their availability, simplicity, possibility of modifications, stability and biocompatibility. They are, on the one hand, an useful tool in advanced analytical chemistry, in particular for studying of biologically-relevant processes, but also important as functional parts of the systems designed for controlled and targeted delivery of medicaments for treatment of a variety of diseases and for imaging. So far, thousands of compounds and systems have been developed for the above-mentioned purposes, but there are only a few reviews dealing with these topics. The aim of this review is, thus, to summarize recent applications of nano-structured inorganic materials in the field of drug delivery, bioimaging and bioanalytics, and to give a prospective from the standpoint of biology-related applications.
T2  - Biologica Nyssana
T1  - Inorganic Nanoparticles In Biology: Drug Carriers And Auxiliary Tools In Bioimaging And Bioanalytics
VL  - 9
IS  - 1
SP  - 1
EP  - 19
DO  - 10.5281/zenodo.1470841
ER  - 
@article{
author = "Matijević, Milica and Popović, Iva A. and Stepić, Milutin and Nešić, Maja D. and Radoičić, Marija B. and Stanković, Maja and Šaponjić, Zoran and Petković, Marijana",
year = "2018",
abstract = "Among various nano-scaled materials composed from a spectrum of chemical compounds, inorganic nanoparticles are very attractive due to their physico-chemical properties, as well as their availability, simplicity, possibility of modifications, stability and biocompatibility. They are, on the one hand, an useful tool in advanced analytical chemistry, in particular for studying of biologically-relevant processes, but also important as functional parts of the systems designed for controlled and targeted delivery of medicaments for treatment of a variety of diseases and for imaging. So far, thousands of compounds and systems have been developed for the above-mentioned purposes, but there are only a few reviews dealing with these topics. The aim of this review is, thus, to summarize recent applications of nano-structured inorganic materials in the field of drug delivery, bioimaging and bioanalytics, and to give a prospective from the standpoint of biology-related applications.",
journal = "Biologica Nyssana",
title = "Inorganic Nanoparticles In Biology: Drug Carriers And Auxiliary Tools In Bioimaging And Bioanalytics",
volume = "9",
number = "1",
pages = "1-19",
doi = "10.5281/zenodo.1470841"
}
Matijević, M., Popović, I. A., Stepić, M., Nešić, M. D., Radoičić, M. B., Stanković, M., Šaponjić, Z.,& Petković, M.. (2018). Inorganic Nanoparticles In Biology: Drug Carriers And Auxiliary Tools In Bioimaging And Bioanalytics. in Biologica Nyssana, 9(1), 1-19.
https://doi.org/10.5281/zenodo.1470841
Matijević M, Popović IA, Stepić M, Nešić MD, Radoičić MB, Stanković M, Šaponjić Z, Petković M. Inorganic Nanoparticles In Biology: Drug Carriers And Auxiliary Tools In Bioimaging And Bioanalytics. in Biologica Nyssana. 2018;9(1):1-19.
doi:10.5281/zenodo.1470841 .
Matijević, Milica, Popović, Iva A., Stepić, Milutin, Nešić, Maja D., Radoičić, Marija B., Stanković, Maja, Šaponjić, Zoran, Petković, Marijana, "Inorganic Nanoparticles In Biology: Drug Carriers And Auxiliary Tools In Bioimaging And Bioanalytics" in Biologica Nyssana, 9, no. 1 (2018):1-19,
https://doi.org/10.5281/zenodo.1470841 . .

Structural characterization of transferrin-bound ruthenium(II) terpyridine complexes

Matijević, Milica; Cindrić, Marina; Petković, Marijana; Nišavić, Marija

(2018)

TY  - CONF
AU  - Matijević, Milica
AU  - Cindrić, Marina
AU  - Petković, Marijana
AU  - Nišavić, Marija
PY  - 2018
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/7921
C3  - FEBS OPEN BIO
T1  - Structural characterization of transferrin-bound ruthenium(II) terpyridine complexes
VL  - 8
IS  - 1
SP  - 406+
DO  - 10.1002/2211-5463.12453
ER  - 
@conference{
author = "Matijević, Milica and Cindrić, Marina and Petković, Marijana and Nišavić, Marija",
year = "2018",
journal = "FEBS OPEN BIO",
title = "Structural characterization of transferrin-bound ruthenium(II) terpyridine complexes",
volume = "8",
number = "1",
pages = "406+",
doi = "10.1002/2211-5463.12453"
}
Matijević, M., Cindrić, M., Petković, M.,& Nišavić, M.. (2018). Structural characterization of transferrin-bound ruthenium(II) terpyridine complexes. in FEBS OPEN BIO, 8(1), 406+.
https://doi.org/10.1002/2211-5463.12453
Matijević M, Cindrić M, Petković M, Nišavić M. Structural characterization of transferrin-bound ruthenium(II) terpyridine complexes. in FEBS OPEN BIO. 2018;8(1):406+.
doi:10.1002/2211-5463.12453 .
Matijević, Milica, Cindrić, Marina, Petković, Marijana, Nišavić, Marija, "Structural characterization of transferrin-bound ruthenium(II) terpyridine complexes" in FEBS OPEN BIO, 8, no. 1 (2018):406+,
https://doi.org/10.1002/2211-5463.12453 . .
18
21